How a Cure Cancer-backed researcher just made it into Nature
A researcher supported by Cure Cancer has reached a remarkable milestone, with his work on how diet shapes immune cell survival published in Nature, one of the most prestigious scientific journals in the world.
Dr Anthony Zhian Chen, a Senior Research Fellow and Group Leader at the University of Queensland's Frazer Institute, is a joint first author on the paper "Lipid metabolism drives dietary effects on T cell ferroptosis and immunity." The discovery reveals a surprising connection between what we eat and how effectively our immune system can respond to cancer.
A discovery hiding in plain sight
At the centre of this research is a process called ferroptosis, a specific form of programmed cell death that occurs when cells accumulate too much oxidative damage in their fats and can no longer sustain themselves.
T cells, the immune cells responsible for identifying and clearing cancer from the body, are especially sensitive to ferroptosis. When too many T cells die this way, the immune system's ability to mount an effective anti-cancer response is weakened.
What Dr Chen and his collaborators found is that T cell vulnerability to ferroptosis is not fixed. The balance of polyunsaturated fatty acids (PUFAs) and monounsaturated fatty acids (MUFAs) in the diet fundamentally shapes T cell resilience, and therefore their ability to drive immune responses. Put simply: what we eat influences whether our immune cells live long enough to do their job.
This effect was consistently observed in human T cells as well, where plasma lipid profiles correlated with ferroptosis vulnerability across multiple healthy cohorts, suggesting a conserved mechanism that could one day be leveraged to improve cancer outcomes.
Why this matters for cancer
The implications reach beyond basic biology. This research points to the possibility of strategically manipulating diet-derived lipid levels to boost the quality of adaptive immunity, including in the context of cancer immunotherapy and vaccines.
For people undergoing T cell-based cancer treatments, including emerging CAR T cell therapies, understanding what keeps these immune cells active and alive could be the difference between a treatment that works and one that doesn't.
This is not a simple "eat this, cure cancer" story. It is something more foundational: evidence that the biological environment we create through nutrition shapes the tools our immune system has available when it needs them most.
